Hydrochloric Acid → HCID 71281241, compound

HRID 1045411Notes

Reaction equation

HRID 1045411 reaction equation
[N:1]1[CH:2]=[C:3]([C:10]([NH:12][C:13]2[CH:14]=[C:15]([C:20]3[N:24]=[C:23]([CH2:25][N:26](C)C(=O)OC(C)(C)C)[O:22][N:21]=3)[CH:16]=[CH:17][C:18]=2[CH3:19])=[O:11])[N:4]2[CH:9]=[CH:8][CH:7]=[CH:6][C:5]=12.Cl>C(#N)C.O1CCOCC1.O>[NH2:26][CH2:25][C:23]1[O:22][N:21]=[C:20]([C:15]2[CH:16]=[CH:17][C:18]([CH3:19])=[C:13]([NH:12][C:10]([C:3]3[N:4]4[CH:9]=[CH:8][CH:7]=[CH:6][C:5]4=[N:1][CH:2]=3)=[O:11])[CH:14]=2)[N:24]=1

Participants

6

Procedure

To a stirring suspension of tert-butyl (3-(3-(imidazo[1,2-a]pyridine-3-carboxamido)-4-methylphenyl)-1,2,4-oxadiazol-5-yl)methyl(methyl)carbamate (F54) (90 mg, 0.195 mmol) in acetonitrile (1 mL) was added 4N HCl in dioxane (1 mL) and water (0.5 mL). The reaction mixture was stirred at room temperature for 45 minutes. Then, the solvent was concentrated and the crude product was dried under high vacuum. The crude product N-(5-(5-(aminomethyl)-1,2,4-oxadiazol-3-yl)-2-methylphenyl)imidazo[1,2-a]pyridine-3-carboxamide (26) was used in the next step without further purification. 1H NMR (400 MHz, d6-DMSO) δ 10.04 (s, 1H), 9.46-9.44 (m, 1H), 8.74 (s, 2H), 8.63 (s, 1H), 8.15 (d, J=2.0 Hz, 1H), 7.86-7.80 (m, 2H), 7.59-7.54 (m, 1H), 7.55 (d, J=8.4 Hz, 1H), 7.23-7.20 (m, 1H), 4.62 (s, 2H), 2.39 (s, 3H). MS m/z 349.4 (M+1)+.

Workup

  1. concentrationThen, the solvent was concentrated
  2. dry with materialthe crude product was dried under high vacuum
  3. customThe crude product N-(5-(5-(aminomethyl)-1,2,4-oxadiazol-3-yl)-2-methylphenyl)imidazo[1,2-a]pyridine-3-carboxamide (26) was used in the next step without further purification

Sources & evidence

ORD record
ord-58bdf4c9be5b47fe8d9971f1f343f7f3
Source dataset
uspto-grants-2013_10
Patent number
US08569283B2

Reaction notes

Loading…